Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 184

1.

[Peritoneal dialysis catheter infection with abscess of the abdominal wall in a ADPKD patient].

Polese L, Borrelli S, Conte G, De Nicola L, Minutolo R, Vita C, Peruzzu N, Netti A, De Stefano T, Provenzano M, Garofalo C.

G Ital Nefrol. 2019 Jul 24;36(4). pii: 2019-vol4. Italian.

PMID:
31373467
2.

[Role of Ambulatory Blood Pressure Monitoring (ABPM) in chronic kidney patients: a review].

Netti A, Borrelli S, Peruzzu N, Polese L, Vita C, De Stefano T, Conte G, De Nicola L, Minutolo R, Provenzano M, Garofalo C.

G Ital Nefrol. 2019 Jun 11;36(3). pii: 2019-vol3. Italian.

PMID:
31250998
3.

[Infected hepatic cyst in ADPKD patient in peritoneal dialysis].

Peruzzu N, Borrelli S, Netti A, De Stefano T, Vita C, Sabatino M, Salzano M, Conte G, De Nicola L, Minutolo R, Garofalo C.

G Ital Nefrol. 2019 Apr;36(2). pii: 2019-vol2. Italian.

PMID:
30983178
4.

Evaluation and training of Executive Functions in genocide survivors. The case of Yazidi children.

Pellizzoni S, Apuzzo GM, De Vita C, Agostini T, Passolunghi MC.

Dev Sci. 2019 Sep;22(5):e12798. doi: 10.1111/desc.12798. Epub 2019 Feb 20.

PMID:
30620434
5.

Antileukotrienes improve naso-ocular symptoms and biomarkers in patients with NARES and asthma.

De Corso E, Anzivino R, Galli J, Baroni S, Di Nardo W, De Vita C, Salvati A, Autilio C, Settimi S, Mele D, Paludetti G, Mullol J.

Laryngoscope. 2019 Mar;129(3):551-557. doi: 10.1002/lary.27576. Epub 2018 Nov 26.

PMID:
30478909
6.

Dietary Salt Restriction in Chronic Kidney Disease: A Meta-Analysis of Randomized Clinical Trials.

Garofalo C, Borrelli S, Provenzano M, De Stefano T, Vita C, Chiodini P, Minutolo R, De Nicola L, Conte G.

Nutrients. 2018 Jun 6;10(6). pii: E732. doi: 10.3390/nu10060732. Review.

7.

High level production of a recombinant acid stable exoinulinase from Aspergillus kawachii.

Chesini M, Wagner E, Baruque DJ, Vita CE, Cavalitto SF, Ghiringhelli PD, Rojas NL.

Protein Expr Purif. 2018 Jul;147:29-37. doi: 10.1016/j.pep.2018.02.007. Epub 2018 Feb 15.

PMID:
29454668
8.

[Hyperuricaemia and Chronic Kidney Disease].

Garofalo C, De Stefano T, Vita C, Vinci G, Balia F, Nettuno F, Scarpati L, Sguazzo A, Sagliocchi A, Pacilio M, Minutolo R, De Nicola L, Borrelli S.

G Ital Nefrol. 2018 Feb;35(1). pii: 2018-vol1. Review. Italian.

PMID:
29390240
9.

Prognostic value of nasal cytology and clinical factors in nasal polyps development in patients at risk: can the beginning predict the end?

De Corso E, Lucidi D, Battista M, Romanello M, De Vita C, Baroni S, Autilio C, Galli J, Paludetti G.

Int Forum Allergy Rhinol. 2017 Sep;7(9):861-867. doi: 10.1002/alr.21979. Epub 2017 Jun 30.

PMID:
28665504
10.

Homocysteine metabolism in children and adolescents with epidermolysis bullosa.

De Giuseppe R, Venturelli G, Guez S, Salera S, De Vita C, Consonni D, Dellanoce C, Bamonti F, Chiarelli G, Manzoni F, Maiavacca R, Esposito S.

BMC Pediatr. 2016 Oct 29;16(1):173.

11.

Oxidative status in treatment-naïve essential thrombocythemia: a pilot study in a single center.

Iurlo A, De Giuseppe R, Sciumè M, Cattaneo D, Fermo E, De Vita C, Consonni D, Maiavacca R, Bamonti F, Gianelli U, Cortelezzi A.

Hematol Oncol. 2017 Sep;35(3):335-340. doi: 10.1002/hon.2264. Epub 2015 Oct 6.

PMID:
26437571
12.

Correlation between salivary and serum oxidized LDL levels: a pilot study on overweight/obese subjects.

De Giuseppe R, Cossellu G, Vigna L, Dicorato F, De Vita C, Venturelli G, Bamonti F, Maiavacca R, Farronato G.

J Oral Pathol Med. 2015 Nov;44(10):884-7. doi: 10.1111/jop.12322. Epub 2015 Mar 28.

PMID:
25816896
13.

Effect of Acetaldehyde Intoxication and Withdrawal on NPY Expression: Focus on Endocannabinoidergic System Involvement.

Plescia F, Brancato A, Marino RA, Vita C, Navarra M, Cannizzaro C.

Front Psychiatry. 2014 Oct 1;5:138. doi: 10.3389/fpsyt.2014.00138. eCollection 2014.

14.

Analytical performance and method comparison study of the total homocysteine immunoassay on the AIA 600II analyser.

Novembrino C, De Giuseppe R, de Liso F, De Vita C, Cortelezzi A, Torresani E, Maiavacca R, Romero I, Bellati P, Bamonti F.

Clin Chem Lab Med. 2013 Jun 29;51(11):e273-5. doi: 10.1515/cclm-2013-0343. No abstract available.

15.

Combinatorial optimization of a CD4-mimetic miniprotein and cocrystal structures with HIV-1 gp120 envelope glycoprotein.

Stricher F, Huang CC, Descours A, Duquesnoy S, Combes O, Decker JM, Kwon YD, Lusso P, Shaw GM, Vita C, Kwong PD, Martin L.

J Mol Biol. 2008 Oct 3;382(2):510-24. doi: 10.1016/j.jmb.2008.06.069. Epub 2008 Jul 1.

16.

Nanoparticles from polylactide and polyether block copolymers: formation, properties, encapsulation, and release of pyrene--fluorescent model of hydrophobic drug.

Slomkowski S, Gadzinowski M, Sosnowski S, Radomska-Galant I, Pucci A, De Vita C, Ciardelli F.

J Nanosci Nanotechnol. 2006 Sep-Oct;6(9-10):3242-51.

PMID:
17048543
17.

Design of miniproteins by the transfer of active sites onto small-size scaffolds.

Stricher F, Martin L, Vita C.

Methods Mol Biol. 2006;340:113-49. Review.

PMID:
16957335
18.

Evidence that intermittent structured treatment interruption, but not immunization with ALVAC-HIV vCP1452, promotes host control of HIV replication: the results of AIDS Clinical Trials Group 5068.

Jacobson JM, Pat Bucy R, Spritzler J, Saag MS, Eron JJ Jr, Coombs RW, Wang R, Fox L, Johnson VA, Cu-Uvin S, Cohn SE, Mildvan D, O'Neill D, Janik J, Purdue L, O'Connor DK, Vita CD, Frank I; National Institute of Allergy and Infectious Diseases-AIDS Clinical Trials Group 5068 Protocol Team.

J Infect Dis. 2006 Sep 1;194(5):623-32. Epub 2006 Aug 1.

PMID:
16897661
19.

Modulating the affinity and the selectivity of engineered calmodulin EF-Hand peptides for lanthanides.

Clainche LL, Figuet M, Montjardet-Bas V, Blanchard S, Vita C.

Biotechnol Bioeng. 2006 Sep 5;95(1):29-36.

PMID:
16637059
20.
21.

Synthesis and biological studies of nociceptin derivatives containing the DTPA chelating group for further labeling with therapeutic radionuclides.

Ligeti M, Gündüz O, Magyar A, Kató E, Rónai AZ, Vita C, Varga I, Hudecz F, Tóth G, Borsodi A, Benyhe S.

Peptides. 2005 Jul;26(7):1159-66. Epub 2005 Mar 2.

PMID:
15949634
22.

Scorpion-toxin mimics of CD4 in complex with human immunodeficiency virus gp120 crystal structures, molecular mimicry, and neutralization breadth.

Huang CC, Stricher F, Martin L, Decker JM, Majeed S, Barthe P, Hendrickson WA, Robinson J, Roumestand C, Sodroski J, Wyatt R, Shaw GM, Vita C, Kwong PD.

Structure. 2005 May;13(5):755-68.

23.

A high-throughput fluorescence polarization assay specific to the CD4 binding site of HIV-1 glycoproteins based on a fluorescein-labelled CD4 mimic.

Stricher F, Martin L, Barthe P, Pogenberg V, Mechulam A, Menez A, Roumestand C, Veas F, Royer C, Vita C.

Biochem J. 2005 Aug 15;390(Pt 1):29-39.

24.

Engineering strontium binding affinity in an EF-hand motif: a quantum chemical and molecular dynamics study.

Rinaldo D, Vita C, Field MJ.

J Biomol Struct Dyn. 2004 Dec;22(3):281-97.

PMID:
15473703
25.

RANTES (CCL5) induces a CCR5-dependent accelerated shedding of syndecan-1 (CD138) and syndecan-4 from HeLa cells and forms complexes with the shed ectodomains of these proteoglycans as well as with those of CD44.

Charnaux N, Brule S, Chaigneau T, Saffar L, Sutton A, Hamon M, Prost C, Lievre N, Vita C, Gattegno L.

Glycobiology. 2005 Feb;15(2):119-30. Epub 2004 Sep 8.

PMID:
15355933
26.

Styrylquinolines, integrase inhibitors acting prior to integration: a new mechanism of action for anti-integrase agents.

Bonnenfant S, Thomas CM, Vita C, Subra F, Deprez E, Zouhiri F, Desmaële D, D'Angelo J, Mouscadet JF, Leh H.

J Virol. 2004 Jun;78(11):5728-36.

27.

Nanostructured hybrid materials from aqueous polymer dispersions.

Castelvetro V, De Vita C.

Adv Colloid Interface Sci. 2004 May 20;108-109:167-85.

PMID:
15072940
28.

Crystal structure of the broadly cross-reactive HIV-1-neutralizing Fab X5 and fine mapping of its epitope.

Darbha R, Phogat S, Labrijn AF, Shu Y, Gu Y, Andrykovitch M, Zhang MY, Pantophlet R, Martin L, Vita C, Burton DR, Dimitrov DS, Ji X.

Biochemistry. 2004 Feb 17;43(6):1410-7.

PMID:
14769016
29.

Interaction of RANTES with syndecan-1 and syndecan-4 expressed by human primary macrophages.

Slimani H, Charnaux N, Mbemba E, Saffar L, Vassy R, Vita C, Gattegno L.

Biochim Biophys Acta. 2003 Oct 31;1617(1-2):80-8.

30.

Purification, characterization, and immunogenicity of a soluble trimeric envelope protein containing a partial deletion of the V2 loop derived from SF162, an R5-tropic human immunodeficiency virus type 1 isolate.

Srivastava IK, Stamatatos L, Kan E, Vajdy M, Lian Y, Hilt S, Martin L, Vita C, Zhu P, Roux KH, Vojtech L, C Montefiori D, Donnelly J, Ulmer JB, Barnett SW.

J Virol. 2003 Oct;77(20):11244-59.

31.

Binding of the CC-chemokine RANTES to syndecan-1 and syndecan-4 expressed on HeLa cells.

Slimani H, Charnaux N, Mbemba E, Saffar L, Vassy R, Vita C, Gattegno L.

Glycobiology. 2003 Sep;13(9):623-34. Epub 2003 May 28.

PMID:
12773479
32.

Engineering new metal specificity in EF-hand peptides.

Le Clainche L, Plancque G, Amekraz B, Moulin C, Pradines-Lecomte C, Peltier G, Vita C.

J Biol Inorg Chem. 2003 Feb;8(3):334-40. Epub 2002 Nov 20.

PMID:
12589569
33.

Rational design of a CD4 mimic that inhibits HIV-1 entry and exposes cryptic neutralization epitopes.

Martin L, Stricher F, Missé D, Sironi F, Pugnière M, Barthe P, Prado-Gotor R, Freulon I, Magne X, Roumestand C, Ménez A, Lusso P, Veas F, Vita C.

Nat Biotechnol. 2003 Jan;21(1):71-6. Epub 2002 Dec 16.

PMID:
12483221
34.

Peripheral neuropathy associated with mitochondrial disorders: 8 cases and review of the literature.

Bouillot S, Martin-Négrier ML, Vital A, Ferrer X, Lagueny A, Vincent D, Coquet M, Orgogozo JM, Bloch B, Vita C.

J Peripher Nerv Syst. 2002 Dec;7(4):213-20. Review.

PMID:
12477166
35.

Engineering novel bioactive mini-proteins from small size natural and de novo designed scaffolds.

Martin L, Vita C.

Curr Protein Pept Sci. 2000 Dec;1(4):403-30. Review.

PMID:
12369907
36.

Heparin-aggregated RANTES can be crystallised.

Stura EA, Martin L, Lortat-Jacob H, Vivès R, Vita C.

Acta Crystallogr D Biol Crystallogr. 2002 Oct;58(Pt 10 Pt 1):1670-3. Epub 2002 Sep 26.

PMID:
12351884
37.

Role of disulfide bonds in folding and activity of leiurotoxin I: just two disulfides suffice.

Zhu Q, Liang S, Martin L, Gasparini S, Ménez A, Vita C.

Biochemistry. 2002 Sep 24;41(38):11488-94.

PMID:
12234192
38.

Synthesis and characterization of biologically functional biotinylated RANTES.

Vita C, Drakopoulou E, Ylisastigui L, Bakri Y, Vizzavona J, Martin L, Parmentier M, Gluckman JC, Benjouad A.

J Immunol Methods. 2002 Aug 1;266(1-2):53-65.

PMID:
12133622
39.

Solid-phase synthesis of peptides containing the spin-labeled 2,2,6,6-tetramethylpiperidine-1-oxyl-4-amino-4-carboxylic acid (TOAC).

Martin L, Ivancich A, Vita C, Formaggio F, Toniolo C.

J Pept Res. 2001 Nov;58(5):424-32.

PMID:
11892851
40.

Structural and functional analysis of the RANTES-glycosaminoglycans interactions.

Martin L, Blanpain C, Garnier P, Wittamer V, Parmentier M, Vita C.

Biochemistry. 2001 May 29;40(21):6303-18.

PMID:
11371192
41.

Characterization of the internal motions of a chimeric protein by 13C NMR highlights the important dynamic consequences of the engineering on a millisecond time scale.

Wolff N, Guenneugues M, Gilquin B, Drakopoulou E, Vita C, Ménez A, Zinn-Justin S.

Eur J Biochem. 2000 Nov;267(22):6519-33.

42.
43.

Synthesis and NMR solution structure of an alpha-helical hairpin stapled with two disulfide bridges.

Barthe P, Rochette S, Vita C, Roumestand C.

Protein Sci. 2000 May;9(5):942-55.

44.

[Acute epiglottitis in children: current criteria for the diagnosis and treatment].

Berni Canani F, Mansi N, Natale A, De Vita C.

Acta Otorhinolaryngol Ital. 1999 Oct;19(5):272-5. Italian.

PMID:
10827801
45.

Synthesis and antibody recognition of mucin 1 (MUC1)-alpha-conotoxin chimera.

Drakopoulou E, Uray K, Mezö G, Price MR, Vita C, Hudecz F.

J Pept Sci. 2000 Apr;6(4):175-85.

PMID:
10809390
46.

Synthesis and immunological studies of alpha-conotoxin chimera containing an immunodominant epitope from the 268-284 region of HSV gD protein.

Mezo G, Drakopoulou E, Paál V, Rajnavölgyi E, Vita C, Hudecz F.

J Pept Res. 2000 Jan;55(1):7-17.

PMID:
10667856
47.

Rational engineering of a miniprotein that reproduces the core of the CD4 site interacting with HIV-1 envelope glycoprotein.

Vita C, Drakopoulou E, Vizzavona J, Rochette S, Martin L, Ménez A, Roumestand C, Yang YS, Ylisastigui L, Benjouad A, Gluckman JC.

Proc Natl Acad Sci U S A. 1999 Nov 9;96(23):13091-6.

48.

Prognostic indices in heart transplant candidates after the first hospitalization triggered by the need for intravenous pharmacologic circulatory support.

Gronda EG, Barbieri P, Frigerio M, Mangiavacchi M, Oliva F, Quaini E, Andreuzzi B, Garascia A, De Vita C, Pellegrini A.

J Heart Lung Transplant. 1999 Jul;18(7):654-63.

PMID:
10452341
49.

A gradual disruption of tight side-chain packing: 2D 1H-NMR characterization of acid-induced unfolding of CHABII.

Song J, Jamin N, Gilquin B, Vita C, Ménez A.

Nat Struct Biol. 1999 Feb;6(2):129-34.

PMID:
10048923
50.

Effect of RANTES on the infection of monocyte-derived primary macrophages by human immunodeficiency virus type 1 and type 2.

Ylisastigui L, Amzazi S, Bakri Y, Vizzavona J, Vita C, Gluckman JC, Benjouad A.

Biomed Pharmacother. 1998;52(10):447-53.

PMID:
9921414

Supplemental Content

Support Center